Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor

BACKGROUND: IDH-mutant astrocytoma and oligodendroglioma have an indolent natural history and are recognized as distinct entities of neoplasms. There is little knowledge on the molecular differences between IDH-mutant astrocytoma and oligodendroglioma grade 2. Therefore, we investigated the multiomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Binghao, Xia, Yu, Yang, Fengchun, Wang, Yaning, Wang, Yuekun, Wang, Yadong, Dai, Congxin, Wang, Yu, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919570/
https://www.ncbi.nlm.nih.gov/pubmed/35287567
http://dx.doi.org/10.1186/s10020-022-00454-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919570/
https://www.ncbi.nlm.nih.gov/pubmed/35287567
http://dx.doi.org/10.1186/s10020-022-00454-z

Ejemplares similares